Radiofrequency treatment for small nonfunctioning pancreatic tumors
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests whether heating (radiofrequency) treatment guided by a special ultrasound scope can control small pancreatic neuroendocrine tumors. It may help patients whose tumors are very small and do not release hormones.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your pancreatic tumor/mass is smaller than 2 cm on MRI (or CT if MRI can’t be used)
- A biopsy shows a pancreatic neuroendocrine tumor, and Ki-67 is under 3% (a marker of slow growth)
- Your tumor is non-secretory, meaning it does not make hormones that cause symptoms
- Special ultrasound (high echo-endoscopy) shows uniform contrast uptake, and the area does not look near the main pancreas or bile ducts
- Your scan shows no FDG “hot spots” on PET (no higher sugar activity in the tumor)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults over time who are treated for a pancreatic tumor using ultrasound-guided radiofrequency through a thin needle. It aims to understand what happens after treatment and how patients do, so future care can improve.
This trial tests a procedure that uses an endoscope and ultrasound to heat (radiofrequency ablate) pancreatic neuroendocrine tumors. It may help shrink tumors while aiming to be a less invasive option.
This trial tests a minimally invasive endoscopic procedure that uses heat to treat certain pancreatic cysts (fluid-filled sacs) and small neuroendocrine tumors (hormone-producing growths). It may be an option if surgery isn't possible or if you prefer to avoid it.
This trial tests a treatment that uses heat from a probe inserted through an endoscope to destroy pancreatic tumors that cannot be removed with surgery. It may help shrink or control the tumor and could be an option if other treatments have not worked.
This trial tests a new treatment that uses an endoscope (a thin, flexible tube with a camera) to deliver heat energy directly to certain small tumors in the pancreas or adrenal gland. It may be an option for people who cannot have surgery or whose tumors are growing slowly.
This trial combines two treatments for advanced pancreatic cancer that hasn't spread: a special endoscopic procedure that uses heat to destroy cancer cells (radiofrequency ablation) and a standard chemotherapy drug combination (FOLFIRINOX). The goal is to see if this combination is safe and can help control the tumor better than chemotherapy alone.
Hear when a new Neuroendocrine Tumor Grade 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.